Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design

References

• Mehnert W, Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 2012;64:83–101
   Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–77
   PubMed Web of Science ®Google Scholar
• Mühlen AZ, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled release drug delivery – drug release and release mechanism. Eur J Pharm Biopharm 1998;45:149–55
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 2008;129:1–10
   PubMed Web of Science ®Google Scholar
• Zheng W, Jain A, Papoutsakis D, et al. Selection of oral bioavailability enhancing formulations during drug discovery. Drug Dev Ind Pharm 2012;38:235–47
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Shokri J, Fallahi S, et al. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.980426
   Google Scholar
• Khurana S, Jain NK, Bedi PMS. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation. Drug Dev Ind Pharm 2014. [Epub ahead of print]. doi:10.3109/03639045.2014.950586
   Google Scholar
• Arai H, Suzuki T, Kaseda C, Takayama K. Effect of an experimental design for evaluating the nonlinear optimal formulation of theophylline tablets using a bootstrap resampling technique. Chem Pharm Bull 2009;57:572–9
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part-I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27–105
   PubMed Web of Science ®Google Scholar
• Nazzal S, Khan M. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS PharmSciTech 2002;3:23–31
   Google Scholar
• Gonzalez-Mira E, Egea M, Souto E, et al. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2011;22:95–101
   Web of Science ®Google Scholar
• Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000;67:201–14
   PubMed Web of Science ®Google Scholar
• Gupta A, Ram SG, Ganga S. Development, evaluation and optimization of extended release buccal tablets prepared using progressive hydration technology. Int J Drug Deliv 2010;2:37–48
   Google Scholar
• Narendar D, Kishan V. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv 2014. [Epub ahead of print]. doi:10.3109/10717544.2014.914986
   Google Scholar
• Hao J, Wang F, Wang X, et al. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci 2012;47:497–505
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627–38
   PubMed Web of Science ®Google Scholar
• Swetha A, Buchi NN. Development and validation of rp-hplc-pda method for the estimation of nisoldipine in bulk and formulations. Ind J Pharm Sci 2012;4:88–91
   Google Scholar
• Kathe N, Henriksen B, Chauhan H. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations. Drug Dev Ind Pharm 2014;40:1565–75
   PubMed Web of Science ®Google Scholar
• Vinay Kumar V, Raghavendra C, Rojarani K, et al. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B 2012;95:1–9
   PubMed Web of Science ®Google Scholar
• Howard MD, Lu X, Jay M, Dziubla TD. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Dev Ind Pharm 2012;38:1270–9
   PubMed Web of Science ®Google Scholar
• Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 1997;157:171–9
   PubMed Web of Science ®Google Scholar
• Madhu B, Raju J, Karthik Yadav J, et al. Enhanced intestinal absorption and bioavailability of raloxifene hydrochloride via lyophilized solid lipid nanoparticles. Adv Powder Technol 2013;24:393–402
   Web of Science ®Google Scholar
• Zhang Q, Yang G, Liu H, et al. Preparation of a novel glycidyl methacrylate-based monolith and its application for the determination of m-nisoldipine in human plasma. J Chromatogr Sci 2010;48:517–22
   PubMed Web of Science ®Google Scholar
• Li M, Wang Q, Wang C, et al. Tissues distribution of R-(−)- and S-(+)-m-nisoldipine after single enantiomer administration in rats. Drug Dev Ind Pharm 2009;35:65–72
   PubMed Web of Science ®Google Scholar
• Dai S, McNeill JH. Fructose-induced hypertension in rats is concentration- and duration-dependent. J Pharmacol Toxicol Methods 1995;33:101–7
   PubMed Web of Science ®Google Scholar
• Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512–16
   PubMed Web of Science ®Google Scholar
• Sudhir V, Yan L, Rajeev G, Diane JB. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm 2009;377:185–98
   PubMed Web of Science ®Google Scholar
• Torrades F, Saiz Z, García-Hortal JA. Using central composite experimental design to optimize the degradation of black liquor by fenton reagent. Desalination 2011;268:97–102
   Web of Science ®Google Scholar
• Wang Z, Li Q, Zhao X, et al. Preparation, formulation optimization and antitumor actions of mannitol coupling camptothecin nanoparticles. Int J Pharm 2014;465:360–7
   Google Scholar
• Varshosaz J, Ghaffari S, Khoshay MR, et al. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res 2010;20:97–104
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT, Fang JY. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm 2010;36:751–61
   PubMed Web of Science ®Google Scholar
• Choi MJ, Briancon S, Andrieu J, et al. Effect of freeze-drying process conditions on the stability of nanoparticles. Dry Technol 2004;22:335–46
   Web of Science ®Google Scholar
• Dodiya S, Chavhan S, Korde A, Sawant KK. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies. Drug Dev Ind Pharm 2013;39:733–43
   PubMed Web of Science ®Google Scholar
• Parveen R, Ahmad FJ, Iqbal Z, et al. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies. Drug Dev Ind Pharm 2014;40:1206–12
   PubMed Web of Science ®Google Scholar